End-of-day quote
Korea S.E.
18:00:00 2024-05-20 EDT
|
5-day change
|
1st Jan Change
|
9,840
KRW
|
-0.40%
|
|
-1.60%
|
-5.48%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
77,580
|
93,341
|
190,264
|
134,304
|
116,776
|
114,683
|
Enterprise Value (EV)
1 |
69,307
|
88,088
|
176,232
|
117,238
|
113,612
|
111,723
|
P/E ratio
|
14.7
x
|
17.2
x
|
9.52
x
|
10.7
x
|
8.12
x
|
12.5
x
|
Yield
|
0.73%
|
0.6%
|
1.18%
|
1.17%
|
2.99%
|
1.73%
|
Capitalization / Revenue
|
1.37
x
|
1.55
x
|
1.78
x
|
1.57
x
|
1.06
x
|
1.02
x
|
EV / Revenue
|
1.22
x
|
1.47
x
|
1.65
x
|
1.37
x
|
1.03
x
|
0.99
x
|
EV / EBITDA
|
14.6
x
|
17
x
|
7.39
x
|
8.8
x
|
6.39
x
|
9.37
x
|
EV / FCF
|
186
x
|
-34.7
x
|
32.7
x
|
31.2
x
|
-9.04
x
|
78.4
x
|
FCF Yield
|
0.54%
|
-2.89%
|
3.06%
|
3.2%
|
-11.1%
|
1.28%
|
Price to Book
|
2.71
x
|
2.87
x
|
3.62
x
|
2.17
x
|
1.59
x
|
1.45
x
|
Nbr of stocks (in thousands)
|
11,326
|
11,192
|
11,192
|
11,192
|
11,017
|
11,017
|
Reference price
2 |
6,850
|
8,340
|
17,000
|
12,000
|
10,600
|
10,410
|
Announcement Date
|
19-03-18
|
20-03-16
|
21-03-18
|
22-03-17
|
23-03-16
|
24-03-14
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
56,626
|
60,087
|
106,604
|
85,750
|
110,165
|
112,917
|
EBITDA
1 |
4,739
|
5,189
|
23,839
|
13,323
|
17,774
|
11,922
|
EBIT
1 |
4,205
|
4,509
|
22,990
|
12,389
|
16,438
|
10,024
|
Operating Margin
|
7.43%
|
7.5%
|
21.57%
|
14.45%
|
14.92%
|
8.88%
|
Earnings before Tax (EBT)
1 |
4,166
|
4,579
|
22,133
|
14,348
|
17,234
|
10,516
|
Net income
1 |
4,653
|
5,471
|
19,988
|
12,553
|
14,393
|
9,191
|
Net margin
|
8.22%
|
9.1%
|
18.75%
|
14.64%
|
13.06%
|
8.14%
|
EPS
2 |
466.3
|
484.7
|
1,786
|
1,123
|
1,306
|
834.3
|
Free Cash Flow
1 |
371.7
|
-2,541
|
5,395
|
3,754
|
-12,572
|
1,425
|
FCF margin
|
0.66%
|
-4.23%
|
5.06%
|
4.38%
|
-11.41%
|
1.26%
|
FCF Conversion (EBITDA)
|
7.85%
|
-
|
22.63%
|
28.18%
|
-
|
11.96%
|
FCF Conversion (Net income)
|
7.99%
|
-
|
26.99%
|
29.91%
|
-
|
15.51%
|
Dividend per Share
2 |
50.00
|
50.00
|
200.0
|
140.0
|
317.0
|
180.0
|
Announcement Date
|
19-03-18
|
20-03-16
|
21-03-18
|
22-03-17
|
23-03-16
|
24-03-14
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
8,274
|
5,254
|
14,032
|
17,066
|
3,164
|
2,959
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
372
|
-2,541
|
5,395
|
3,754
|
-12,572
|
1,425
|
ROE (net income / shareholders' equity)
|
21%
|
17.9%
|
47%
|
22.1%
|
21.4%
|
12%
|
ROA (Net income/ Total Assets)
|
6.51%
|
5.15%
|
21.2%
|
9.88%
|
9.75%
|
4.91%
|
Assets
1 |
71,432
|
106,130
|
94,369
|
127,001
|
147,623
|
187,137
|
Book Value Per Share
2 |
2,532
|
2,906
|
4,694
|
5,527
|
6,684
|
7,200
|
Cash Flow per Share
2 |
748.0
|
968.0
|
1,110
|
1,026
|
2,541
|
1,540
|
Capex
1 |
237
|
1,796
|
446
|
1,006
|
14,422
|
11,783
|
Capex / Sales
|
0.42%
|
2.99%
|
0.42%
|
1.17%
|
13.09%
|
10.44%
|
Announcement Date
|
19-03-18
|
20-03-16
|
21-03-18
|
22-03-17
|
23-03-16
|
24-03-14
|
|
1st Jan change
|
Capi.
|
---|
| -5.48% | 80.02M | | -7.03% | 14.38B | | -39.46% | 2.89B | | -13.36% | 2.43B | | -15.28% | 1.42B | | -.--% | 1.12B | | +41.44% | 563M | | +85.64% | 503M | | +27.01% | 274M | | -7.75% | 211M |
Medical Imaging Systems
|